Aromatase inhibitors are not suitable for all patients. They are generally not recommended for:
Premenopausal women, as their primary source of estrogen is the ovaries, not peripheral conversion. Patients with severe liver impairment, due to the potential for drug accumulation and toxicity. Individuals with known hypersensitivity to any component of the medication.
